Intrinsiqs

Is Krystal Biotech, Inc. overvalued?

Krystal Biotech, Inc. (KRYS) — key valuation metrics and fundamentals.

No verdict
Price
$345.82
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$10.19B
Dividend yield
0.0%
Return on equity
19.3%
Sector
Healthcare

See the full interactive analysis →

Fair value compares KRYS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.